Assessment of Extrapyramidal Symptoms Associated with Psychotropics Pharmacological Treatments, and Associated Risk Factors
CONCLUSION: Patients treated with paroxetine, imipramine, fluoxetine, or clomipramine had a higher risk of developing di-EPS than patients treated with citalopram. The difference in gender was not significantly related to di-EPS development. Whereas age, smoking, and history of taking antipsychotics were significantly associated with di-EPS development.KEY FINDINGS: • High incidence of drug-induced extrapyramidal symptoms (di-EPS) was reported• Age, smoking, tremor history, and history of taking antipsychotics were risk factors of drug-induced extrapyramidal symptoms.• Patients taking paroxetine, imipramine or fluoxetine had a significantly higher risk of developing di-EPS compared to patients taking citalopram.PMID:33719362 | PMC:PMC7931155 | DOI:10.2174/1745017902117010001
Source: Clinical Practice and Epidemiology in Mental Health - Category: Psychiatry Authors: Dania Abu-Naser Sara Gharaibeh Ahmad Z Al Meslamani Qais Alefan Renad Abunaser Source Type: research
More News: Amitriptyline | Celexa | Citalopram | Databases & Libraries | Epidemiology | Fluoxetine | Imipramine | Jordan Health | Men | Middle East Health | Organic | Paroxetine | Paxil | Prozac | Psychiatry | Science | Smokers | Statistics | Study